MTOR and hepatocellular carcinoma: In our study, we focused on the potential association between CREB3L4 and PI3K/AKT/mTOR pathway in the HCC pathogenesis as it is constitutively activated in a significant proportion of HCC patients, together with significant upregulation in the HCC tissues compared with the adjacent tissues according to our clinical experience and bioinformatic analysis.